ATR
AptarGroup Inc
NYSE: ATR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$127.17
+0.52% today
Updated 2026-10-28
Market cap
$7.92B
P/E ratio
22.47
P/S ratio
2.01x
EPS (TTM)
$5.54
Dividend yield
1.52%
52W range
$102 – $146
Volume
0.4M
AptarGroup Inc (ATR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$127.17
12-Month target
$123.84
2030 Target
—
Intrinsic (DCF)
$99.55
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.3B | $3.5B | $3.6B | $3.8B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 22.47x (capped 25x) · Margin: 9.22%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.